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VAPAbstract Background: The diagnosis of ventilator associated pneumonia (VAP) remains a chal-
lenge because the clinical signs and symptoms lack both sensitivity and speciﬁcity and the selection
of microbiologic diagnostic procedure is still a matter of debate. Objective: To compare the diagnos-
tic value of bronchoscopic BAL and non-bronchoscopic protected BAL in patients with VAP.
Materials and methods: Twenty patients, clinically diagnosed with VAP, were involved in this
research; they were evaluated by bronchoscopic and non-bronchoscopic BAL for diagnosis of
VAP. The sensitivity, speciﬁcity, positive predictive value (PPV) and negative predictive value
(NPV) of bronchoscopic and non-bronchoscopic BAL were calculated, taking clinical pulmonary
infection score (CPIS) of P6 as reference standard. Results: There was a good microbiologic con-
cordance and strong correlation between bronchoscopic BAL and non bronchoscopic BAL in diag-
nosis of VAP. There was a high concordance between CPIS score and both procedures’ results.
Percentage of concordance between CPIS and bronchoscopic BAL was 97.5% and with non bron-
choscopic BAL was 95%. Gram negative organisms were the commonest organisms isolated by
both techniques. Conclusion: Non bronchoscopic BAL is an inexpensive, easy, and useful technique
for microbiologic diagnosis of VAP. This ﬁnding, if veriﬁed, might simplify the approach for the
diagnosis of VAP.
 2015 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
The diagnosis of ventilator associated pneumonia (VAP)
remains a challenge because the clinical signs and symptoms
lack both sensitivity and speciﬁcity and selection of microbio-
logic diagnostic procedure is still a matter of debate [1].
Accurate clinical and microbiologic diagnosis of VAP is
Figure 2 Chest X-ray showing the site of catheter wedge in NB-
BAL.
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but also to prevent their misuse. The invasive diagnostic meth-
ods, including quantitative cultures of distal airway specimens
obtained by using bronchoscopic bronchoalveolar lavage
(BAL) could improve identiﬁcation of patients with true
VAP and selection of appropriate antibiotics [2,3]. However,
bronchoscopy requires technical expertise and adds to the cost
of care. In an attempt to overcome these limitations, non-
bronchoscopic distal airway sampling methods have emerged,
like non-bronchoscopic BAL (NBAL) and non-bronchoscopic
PBS [4,5].
Aim of the work
To compare the diagnostic value of bronchoscopic BAL and
non-bronchoscopic protected BAL in patients with VAP.
Patient and methods
This prospective comparative study was conducted in intensive
care unit (ICU) at Menouﬁa University Hospitals. Patients
older than 17 years who required ventilatory support for more
than 48 h or more with clinical and radiological diagnosis of
VAP according to CPIS score were enrolled. Patients with
diagnosis of community acquired pneumonia or hospital
acquired pneumonia before starting of mechanical ventilation
and who mechanically ventilated in another hospital for 48 h
or more before admission were excluded.
In each patient, Two respiratory samples were collected
which include bronchoscopic BAL and NB-BAL. To avoid
contamination of the lower airways, the non-bronchoscopic
sampling was performed ﬁrst; before either procedure, the ven-
tilatory settings were adjusted by increasing tidal volume by
100 ml and FiO2 to 1.0. All the vital signs including heart rate,
blood pressure, temperature and oxygen saturation were mon-
itored during the procedure. A special elbow adaptor mounted
on the endotracheal tube allows catheter or the ﬂexible bron-
choscope to be inserted while the patient is on the mechanical
ventilator. The seal on the hole of elbow adaptor was open
during the procedure and therefore airway pressure was not
maintained during the procedure. Sedation was maintained
with boluses of 3–5 mg of intravenous midazolam as required
(see Figs. 1 and 2).Figure 1 NB-BAL catheters used in the study.NB-BAL was performed by the double catheter technique.
A sterile suction catheter of size 16 Fr was cut 2–3 cm from the
distal end to give a ﬁnal length of about 47–48 cm and inserted
through the endotracheal tube and blindly advanced into the
distal airways till resistance is felt then the catheter was wedged
in that position. A second 50-cm long sterile suction catheter
of size 8 Fr was passed through the ﬁrst catheter and advanced
as far as possible and chest X ray was done to conﬁrm that the
site of suction tip catheter wedged in the right lung and normal
saline (150 ml) was instilled through the inner tube and aspi-
rate was collected in a sterile container by suction.
Then, bronchoscopic BAL, Using (Pentax FB, 18-TV, with
internal diameter of 2 mm), any patient having contraindica-
tion for ﬁber-optic bronchoscopy is excluded as; 1 – Severe
uncorrected hypoxemia despite the administration of supple-
mental oxygen. 2 – Unstable cardiovascular or hemodynamic
status. 3 – Coagulation defects. The prothrombin concentra-
tion should be greater than 70%, and the platelets count
greater than 60,000/mm [3].
Once the site had been chosen, the bronchoscope was
advanced into a subsegmental bronchus until the tip was
wedged. Care must be taken to avoid ‘‘over wedging” the
bronchoscope, since this can result in additional trauma to
the airway and diminish ﬂuid recovery. A good wedge position
was conﬁrmed by noting slight airway collapse when gentle
suction is applied. A poor wedge position allows leakage of
lavage ﬂuid around the bronchoscope. Optimum ﬂuid recovery
occurs when the bronchoscope completely occludes the bron-
chial lumen of a 3rd or 4th bronchial subsegment. Normal sal-
ine (commercial 0.9 percent NaCl) was used as the instillate.
We used two to three sequential aliquots of 50 mL each.
Using tubing with three way stopcock, a saline-ﬁlled 50 mL
syringe was attached to the side port of the bronchoscope.
The ﬁrst aliquot of saline was instilled slowly and steadily.
After the ﬁrst aliquot of saline was infused, it was recovered
immediately into the same syringe by gentle continuous hand
suction. Suction should be gentle enough that visible airway
collapse should not occur. In patients with marked airway col-
lapse despite gentle suction, the suctioning process was slowed,
and discontinuous suction was used to maximize ﬂuid retrie-
val. When no further ﬂuid could be aspirated, the stopcock
was closed and the syringe (but not the tubing) removed.
The second saline ﬁlled syringe was attached to the tubing
Table 1 Complications among the studied sample of patients
(n= 20).
Complications Studied respiratory samples
tech.
Fisher’s
exact test
P value
NB-BAL
(n= 20)
B-BAL
(n= 20)
No. % No. %
Hypoxemia 4 20.0 10 50.0 3.95 0.04 S
Arrhythmia 5 25.0 10 50.0 2.66 0.10 NS
Bleeding 0 0.0 1 5.0 1.03 0.31 NS
Others 0 0.0 4 23.5 2.50 0.11 NS
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lavage was completed, if desired.
Microbiology processing: All the samples were transported
to our microbiology laboratory within 1 h of collection.
Samples were cultured and were used for quantiﬁcation of bac-
terial load. Bacterial identiﬁcation was done using standard
microbiologic techniques and antibiotic sensitivity was esti-
mated as per National Committee for Clinical Laboratory
Standard (NCCLS). The growths were expressed as number
of colony forming units (CFU)/mL. The thresholds applied
to quantitative cultures for the diagnosis of VAP were
104 CFU/mL for NB-BAL and B-BAL.
Data management: Results were collected, tabulated and
statistically analyzed by an IBM compatible personal com-
puter with SPSS statistical package version 20.
Two types of statistics were done:
(a) Descriptive statistics e.g. number (No), percent (%) for
qualitative data, mean (x), standard deviation (SD)
and range for quantitative data.
(b) Analytic statistics e.g.
 Chi- squared test (v2) was used to study association
between qualitative variables.
 Fisher’s exact test for 2  2 tables when expected cell
count of more than 25% of cases was less than 5.
 Two-by-two tables were used to calculate sensitivity,
speciﬁcity, positive predictive value (PPV), negative pre-
dictive value (NPV) and diagnostic accuracy of BAL and
non BAL in patients of VAP.
 Kappa test is a measure of association (correlation or
reliability) between two measurements of the same indi-
vidual when the measurements are categorical.
 P-valueof (>0.05)was considered statistically insigniﬁcant.
 P-value of (60.05) was considered statistically signiﬁcant.
 P-value of (60.001) was considered statistically highly
signiﬁcant.
Results
We prospectively evaluated 20 patients with high clinical suspi-
cion of VAP, patients’ age ranged between 18 and 70 years
(mean 47.70 ± 16.29). There was a male preponderance in
the study group with a male:female ratio of 2.3:1. Trauma with
disturbed conscious level (DCL) was the commonest cause of
ICU admission. DM and hypertension were the commonest
comorbidities. DCL was the commonest indication for
mechanical ventilation followed by COPD exacerbation.
All patients were diagnosed to have late onset VAP except
seven patients who had early onset VAP. All patients in the
study were on presumptive antibiotic treatment. All patients
had CPIS score >6 and there were either diffuse bilateral or
right sided inﬁltrate on chest X ray. Hypoxemia was the
commonest complication that occurred during both
procedures as shown in Table 1. In NB-BAL, it was detected
in four patients and in bronchoscopic BAL, it was detected
in ten patients. Other complications include tachyarrhythmia
that was detected in NB-BAL with ﬁve patients and in BAL
with ten patients, hemorrhage was detected in one case,
it was mild and mostly as a result of trauma during
bronchoscopic BAL.Microbial cultures were positive in 18 of 20 (90%) samples
of Non-bronchoscopic protected BAL and were positive on 19
of 20 (95%) samples on bronchoscopic BAL as shown in
Table 2, Most of the sample results were polymicrobial on
both procedures except in three cases on NB-BAL and BAL
which were unimicrobial, Klebsiella was the most common
organism isolated (20 of 40 samples) followed by
Acinetobacter (17 of 40) and then pseudomonas (11 of 40).
Among these pathogens, 60% were extended spectrum beta-
lactamase (ESBL) positive and 40% were metallo beta-
lactamase (MBL) positive. Perfect qualitative concordance
(organisms) among the two techniques was seen in 10 out of
20 cases and there is change on one or two organisms between
the two procedures on the remaining samples. Contamination
with MRSA was detected on one case in both procedures and
with candida on NB-BAL (n= 1) and on BAL (n= 2). All
patients included in this study were diagnosed to have VAP
based on CPIS score but there were two samples of NB-BAL
and one sample of BAL showing no growth. Organisms iso-
lated in patient with early onset VAP were mainly polymicro-
bial and mainly gram negative with either ESBL or MBL type
as like the late onset VAP and there is no signiﬁcant change
between the two sampling procedures’ results in the two types
of VAP in our ICU according to the type of microorganisms.
There was a high concordance between CPIS score and
both procedures’ results as shown in Table 3. Percentage of
concordance between CPIS and bronchoscopic BAL was
97.5% and with non bronchoscopic BAL was 95%. The diag-
nostic utility of the two sampling techniques is shown in Fig. 3:
Non-bronchoscopic protected BAL sensitivity, speciﬁcity, PPV
and NPV were 89%, 75%, 77% and 88% respectively and
Bronchoscopic BAL had a sensitivity of 85% and speciﬁcity
of 77%, PPV and NPV were 74% and 82% respectively.
Discussion
Even though the B-BAL has several advantages, the most
important being the ability to direct sampling into the desired
lobe, it is important to emphasize its limitations in resources as
ﬁberoptic bronchoscopes and qualiﬁed operators are not
always readily available thus potentially delaying pathogen-
directed treatment with its harmful consequences [6,7]. Kollef
et al. mentioned that NB-BAL is a simple procedure which
can be performed by resident doctors and paramedics posted
at the ICU after a small demonstration which can reduce the
cost of management of VAP [8]. Similar beneﬁts should be
Table 2 Organisms isolated in microbiologic cultures among the studied sample of patients (n= 20).
Organisms (CFU)/mL Studied respiratory samples Fisher’s exact test P value
NB-BAL (n= 20) B-BAL (n= 20)
No. % No. %
No growth 2 10.0 1 5.0 0.36 0.54 NS
Pseudomonas aerugenisa
ESBL+ 2 10.0 2 10.0 0.28 0.59 NS
MBL 4 20.0 3 15.0 0.17 0.68 NS
Klebsiella spp.
ESBL+ 7 35.0 7 35.0 0.00* 1.00 NS
MBL 3 15.0 3 15.0 0.20 0.66 NS
Acinetobacter spp.
ESBL+ 5 25.0 6 30.0 0.13 0.72 NS
MBL 3 15.0 3 15.0 0.20 0.66 NS
E-coli
ESBL+ 2 10.0 2 10.0 0.28 0.59 NS
MBL 1 5.0 2 10.0 0.36 0.54 NS
Proteus
ESBL+ 2 10.0 1 5.0 0.36 0.54 NS
MBL 0 0.0 0 0.0 – –
Citrobacter
ESBL+ 0 0.0 0 0.0 – –
MBL 1 5.0 1 5.0 0.53 0.47 NS
MRSA
True infection 4 20.0 5 25.0 0.14 0.70 NS
Contaminant 1 5.0 1 5.0 0.53 0.47 NS
Candida
True infection 2 10.0 3 15.0 0.23 0.63 NS
Contaminant 1 5.0 2 10.0 0.36 0.54 NS
Table 3 Concordance among CPIS score and both procedure
culture results.
Sampling
techniques
Kappa
coeﬃcient
%
Concordance
P
value
NB-BAL vs. CPIS 0.90 95 0.04 S
B-BAL vs. CPIS 0.95 97.5 0.04 S
NB-BAL vs. B-
BAL
0.61 82 0.03 S
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Figure 3 Diagnostic validity of NB-BAL and B-BAL in diag-
nosis of VAP (n= 20).
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used in our study have low cost. This study showed that
NB-BAL was less invasive with less compromise of oxygena-
tion than B-BAL. Weardon et al., Ruiz et al., Papazian
et al., and Viola´n et al. reported that complications of invasive
tests were not serious but the most commonly reported compli-
cations were pulmonary hemorrhage (0–14.3%) and pneu-
mothorax (0–8.9%) [9–12]. Pugin et al., Pham et al. and
Rouby et al. showed that previous reports of blind invasive
procedures had yielded conﬂicting evidence mostly because
of variable methodologies, different thresholds of quantitative
studies and reference standards. Blinded invasive procedures
that are used to obtain lower respiratory tract samples may
be done by different techniques as blind bronchial sampling
(BBS), blind protected specimen brush (BPSB) and mini-
BAL. [2,13,14]. In some instances, an unprotected catheter
can be used instead. In the present study, we used 20 pairs
of samples that were isolated from 20 patients requiring
mechanical ventilation and diagnosed to have VAP dependingon CPIS score (CPIS > 6). We used a double catheter tech-
nique in NB-BAL in an attempt to standardize a technique
that is simple, widely available and with low risk of complica-
tions. The study analyzed the performance of the double cathe-
ter technique of NB-BAL with the B-BAL in the same patient
by using the same lavage volume and quantitative threshold.
Pugin et al. enrolled 28 patients in their study comparing the
B-BAL with NB-BAL that was done by mini BAL technique
and CPIS score was used as standard reference [2]. Papazian
et al. enrolled 38 patients comparing Mini BAL with B-BAL
but postmortem cultures were used as reference standard
[15]. Leal-Noval et al. enrolled 38 patients using the protected
blind brush technique for NB-BAL and comparing it with B-
BAL and used CPIS score as standard reference [16].
Minutoli et al. reported the use of a nasogastric tube [17].
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BAL) for BAL [18]. The reference standard in this study was
the clinical pulmonary infection score (CPIS) with a total score
more than six for the diagnosis of VAP. CPIS was proposed by
Pugin et al. and it was compared to quantitative culture of
BAL. [2]. This study showed a high concordance between
CPIS score and both techniques B-BAL and NB-BAL.
Fartoukh et al. found that clinical prediction alone was inaccu-
rate but a modiﬁed CPIS score incorporating a Gram stain of
respiratory tract secretions improved diagnostic accuracy [19].
Fabregas et al. compared CPIS to pathological diagnosis and
found that CPIS had a moderate performance with a sensitiv-
ity between 7% and 77% and speciﬁcity between 42% and
85% [20]. Pham et al. found that CPIS had a high speciﬁcity
in diagnosing VAP compared to quantitative BAL ﬂuid
culture [21]. Luyt et al. was against the use of CPIS score as
reference standard, where they studied 201 mechanically venti-
lated patients in whom strict bronchoscopic criteria were
applied to diagnose or exclude pneumonia and the CPIS did
not differ signiﬁcantly for patients with or without VAP [22].
The use of CPIS to diagnosis VAP was also evaluated in 158
trauma patients and it was found to be not speciﬁc in diagnosis
of VAP [23]. A major limitation of validating CPIS for diag-
nosing VAP is that BAL culture is not a true gold standard
[15,20,24,25]. In addition, the calculation of CPIS was modi-
ﬁed by some authors and different cutoff points were used to
diagnose VAP [25,26]. In this study, we used quantitative cul-
tures for both procedures expressed in colony-forming units
per milliliter. A cutoff point of (104 CFU/mL) was used as
an indication of infection and less than this number was con-
sidered as contamination. Quantitation of bacteria is impor-
tant in invasive procedures used to obtain specimens through
an airway as it is normally colonized with bacteria and the
necessity of an endotracheal tube for mechanical ventilation
and colonization of the trachea by oropharyngeal bacterial
ﬂora is expected [27]. Torres and El-Ebiary reviewed 23 studies
evaluating B-BAL methods and reported that 104 CFU/mL
was the most frequent cutoff used to differentiate colonization
from infection [28]. There was variability in quantitative cul-
tures cutoff point used as a reference standard for B-BAL
and NB-BAL. This explains the sensitivity and speciﬁcity
variability as it inversely varies with cutoff point. Most studies
cite 104 CFU/mL as a positive result; however, a ﬁnding of
103–105 CFU/mL is also considered positive as showed by
Valle´s et al. and Torres et al. [29,30]. All patients who were
enrolled in this study were receiving antibiotics before and at
the time of the procedure. All the cultures are positive except
two cases on BAL and three cases on NB-BAL. When patients
with pneumonia are receiving antimicrobial agents at the time
of sampling, cultures may be negative and concentrations of
bacteria may be below the diagnostic threshold. Timsit et al.
assessed the impact of antimicrobial therapy on the diagnosis
of VAP and he concluded that when patients acquire pneumo-
nia while on antibiotics for infections at extra pulmonary sites,
the microorganisms are resistant to these antibiotics and the
diagnostic yields of BAL are unaffected [31]. Souweine et al.
conﬁrmed and extended the observations of Timsit et al.
[32]. These studies suggest that the sensitivity of PSB and
BAL for the diagnosis of VAP is unchanged in patients who
acquire VAP while on antibiotics for >72 h for treatment of
an extra pulmonary infection. Therefore, for such patients,
lower respiratory tract secretions should be obtained forquantitative culture and microscopic examination before any
changes is made in antimicrobial therapy [31,32].
In performing BAL by both procedures, we used 150 mL of
0.9% saline solution. In a large meta-analysis, there was some
controversy over whether amounts lower than 140 mL would
inﬂuence culture results. Studies in which amounts lower than
140 mL were used presented lower diagnostic accuracy.
However, of the 26 studies selected by this meta-analysis, 7
did not mention the amount of volume in use, and only 6
(26%) used amounts higher than 140 mL, which might have
biased the data. In addition, there were 6 studies that used
amounts of 100 mL [29]. Kollef et al. in their study showed
that NB-BAL done by a respiratory physiotherapist had
shown good microbiologic agreement (83.3%) with broncho-
scopic protected brush. These results signify that blind sam-
pling techniques like NB-BAL are good modalities for
microbiologic diagnosis of VAP [2]. The utility of NB-BAL
for diagnosis of VAP has been demonstrated by other
researchers also, both in clinical as well as autopsy studies.
Rouby et al. showed that the sensitivity and speciﬁcity of
NB-BAL were 70% and 69% respectively, using post-
mortem histologic and bacteriologic analysis of lung as the
gold standard for the diagnosis of VAP [14]. Pugin et al. used
CPIS as the diagnostic criteria for VAP and found that sensi-
tivity, speciﬁcity, and PPV of NB-BAL were 73%, 96%, and
92%, respectively [2]. The sensitivity of quantitative B-BAL
ﬂuid cultures in the literature ranges from 42% to 93%, with
a mean of 73%; the variability reﬂects the characteristics of
the study population, prior administration of antibiotics
(which reduces sensitivity) and the reference test used [15,31].
The speciﬁcity ranges from 45% to 100%, with a mean of
82% in most studies. The sensitivity range of NB-BAL is
63–100% and the speciﬁcity ranges are similar to those
reported for BAL [6,33]. The present study mean results are
comparable to these reports and we hope that this technique
would ﬁnd utility in clinical practice. In the present study,
NB-BAL had an excellent concordance with bronchoscopic
BAL in diagnosis of VAP which proves the fact that despite
it is a blind procedure, samples adequately represent the lower
airway secretions and efﬁciently diagnose VAP in case of dif-
fuse disease involving multiple lobes, and in right lobe pneu-
monia. We speciﬁed the diffuse or right side inﬁltrate in our
study as the NB-BAL is a blind technique and is easily directed
to the right side. That was also done by Leal-Noval et al. who
enrolled patients with right or bilateral pulmonary inﬁltrate in
their study [16]. The present study has several limitations; an
important one is the validity of the exact operating character-
istics (sensitivity, speciﬁcity, PPV, and NPV) for both tech-
niques, which may be questioned in the absence of the gold
standard for the diagnosis of VAP. The diagnostic criteria used
for VAP should have a high sensitivity. This approach is based
on that the risk for not treating a patient with pneumonia
probably outweighs the risk for unnecessary antibiotic admin-
istration [36]. For this reason, CPIS was used as the standard
and was found to have a high sensitivity for the diagnosis of
VAP [8]. However, there are other studies where usefulness
of CPIS for the diagnosis of VAP was questioned as shown
by Croce et al. and Schurink et al., Rouby et al., Chastre
et al. and Torres et al. used the autopsy examination of lung
tissue (bacteriologic and histologic) as a gold standard to
determine the precise diagnostic yield of similar bronchoscopic
and non-bronchoscopic procedures. However, this has a
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diagnostic utility of this approach may be further compro-
mised due to histologic sampling errors, the effects of previous
antibiotic administration on tissue cultures, and problems
related to the timing of postmortem lung examination.
Therefore, one should keep this limitation in mind during
interpretation of the results of our study [23,26,34,35,30].
Another important limitation is that this is a single center
study with a small sample size; its results may not be general-
izable to other settings. However, the main objective of the
study was to compare the microbiologic ﬁndings of the two
techniques and the study achieved this objective. Pugin et al.,
Papazian et al., Kollef et al. and Rouby et al. did larger studies
and had shown comparable results to this study. Till date, the
optimal strategy for the diagnosis of VAP remains to be
deﬁned [2,15,17,14]. The American Thoracic Society guidelines
do provide expert opinion supporting quantitative or semi-
quantitative cultures of respiratory specimens, although the
panel favors invasive quantitative techniques [36].
Conclusion
NBAL is an acceptable alternative to bronchoscopy for the
evaluation of suspected VAP as NBAL is an inexpensive, easy,
requires lesser expertise and useful technique for microbiologic
diagnosis of VAP and has a good microbiologic concordance
with bronchoscopic BAL in distal airway sampling.References
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